Option Care Health (NASDAQ:OPCH) Rating Increased to Strong-Buy at Stephens

Option Care Health (NASDAQ:OPCH) was upgraded by research analysts at Stephens to a “strong-buy” rating in a report released on Thursday,Zacks.com reports.

Other research analysts have also issued research reports about the company. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Friday, October 31st. JMP Securities set a $36.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research note on Monday. TD Cowen reduced their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Finally, Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, December 6th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $36.27.

Option Care Health Stock Performance

NASDAQ OPCH opened at $33.24 on Thursday. The stock has a market capitalization of $5.28 billion, a price-to-earnings ratio of 26.38, a PEG ratio of 2.22 and a beta of 0.80. The business’s 50 day moving average is $28.74 and its two-hundred day moving average is $29.36. Option Care Health has a 12-month low of $22.29 and a 12-month high of $35.53. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by company insiders.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Allworth Financial LP lifted its holdings in Option Care Health by 31.3% in the 3rd quarter. Allworth Financial LP now owns 2,938 shares of the company’s stock valued at $82,000 after purchasing an additional 701 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new position in shares of Option Care Health during the third quarter valued at approximately $217,000. CIBC Bancorp USA Inc. purchased a new stake in Option Care Health in the 3rd quarter worth approximately $488,000. Danske Bank A S purchased a new stake in Option Care Health in the 3rd quarter worth approximately $909,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.